Akari Therapeutics Plc Quarterly Depreciation in USD from Q1 2014 to Q2 2022

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Akari Therapeutics Plc annual/quarterly Depreciation history and growth rate from Q1 2014 to Q2 2022.
  • Akari Therapeutics Plc Depreciation for the quarter ending June 30, 2022 was $0.000.
  • Akari Therapeutics Plc annual Depreciation for 2023 was $144K, a 5.15% decline from 2022.
  • Akari Therapeutics Plc annual Depreciation for 2022 was $152K.
  • Akari Therapeutics Plc annual Depreciation for 2021 was $0.000, a 100% decline from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2022 $0 $0 Apr 1, 2022 Jun 30, 2022 6-K 2022-09-27
Q2 2021 $0 Apr 1, 2021 Jun 30, 2021 6-K 2022-09-27
Q2 2019 $3.78K -$4.59K -54.9% Apr 1, 2019 Jun 30, 2019 6-K 2019-08-29
Q2 2018 $8.37K -$2.58K -23.6% Apr 1, 2018 Jun 30, 2018 6-K 2019-08-29
Q2 2017 $11K +$1.53K +16.3% Apr 1, 2017 Jun 30, 2017 6-K 2018-09-27
Q2 2016 $9.42K Apr 1, 2016 Jun 30, 2016 6-K 2017-08-10
Q1 2016 $8.59K +$7.83K +1025% Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-12
Q1 2015 $764 +$764 Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q1 2014 $0 Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.